Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
January 10, 2007
By: Tim Wright
Editor-in-Chief, Contract Pharma
Peter J. Adamski has been named chief financial officer, Aptuit, Inc. Mr. Adamski has more than 25 years of financial management experience in public and private companies, primarily in the health care and pharmaceutical industries. He most recently served as chief financial officer of Barriersafe Solutions International, where he revamped the company’s accounting, tax and financial reporting functions and was instrumental in the successful sale of the company. Mr. Adamski began his career at Arthur Andersen before joining Johnson & Johnson, where he spent 16 years in roles with increasing responsibility. He also served as chief financial officer of McNeil Specialty Products Co. “Pete brings a robust understanding of complex global business transactions and experienced professional financial management to this position,” stated Michael A. Griffith, Aptuit’s chief executive officer. “We welcome Pete as we transition into a new phase of investment, consolidation and recruitment to expand our global operations while emphasizing superior financial performance.” Mr. Adamski replaces Jon E. Tropsa, who will return to his private consulting practice. Mr. Tropsa will continue to serve as a consultant on a range of issues for Aptuit. Mr. Griffith stated, “On behalf of Aptuit’s investors and managers, I thank Jon for his leadership and tireless effort since joining us full time to acquire and assimilate our platform positions. We could not have done it without him, and we will keep his office lights on because we expect to see a lot of him as we become his client once again.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !